Study Period | 2018-2030 | CAGR | 6.95% |
Historical Period | 2018-2020 | Forecast Period | 2022-2030 |
Base Year | 2021 | Base Year Market Size | USD 5.42 Billion |
Forecast Year | 2030 | Forecast Year Market Size | USD 9.92 Billion |
Largest Market | North America | Fastest Growing Market | Europe |
The global minimally invasive gastrointestinal surgical systems market size was valued at USD 5.42 billion in 2021 and is projected to reach USD 9.92 billion by 2030, registering a CAGR of 6.95% from 2022 to 2030.
Through a relatively small incision, minimally invasive neurosurgery is typically utilised to treat disorders that can manifest in a variety of regions of the brain, spinal cord, or skull base. This type of surgery is known as "keyhole surgery." Conventional surgical treatments are losing ground to their minimally invasive counterparts in terms of popularity. This is due to the fact that minimally invasive procedures require less time for recovery, cause a lower degree of trauma, and require shorter hospital stays. The rise in the benefits of minimally invasive surgeries over traditional open surgeries is a vital factor in the acceleration of market growth. In addition, the rise in the growth of minimally-invasive surgery devices, the rise in the growth of healthcare expenditures, and the rise in the growth of healthcare outcomes are the major factors among other factors that are driving the market for minimally invasive gastrointestinal surgical systems. In addition, an increase in public-private initiatives to support research activities on minimally invasive surgical instruments and an increase in the research and development activities in the market will further create new opportunities for the market for minimally invasive gastrointestinal surgical systems during the forecasted period of 2022-2030. These factors are expected to have a positive impact on the market.
There has been a recent uptick in the amount of money invested in the expansion of healthcare infrastructure, which has led to an increase in evidence of successful and encouraging outcomes from surgical help. Therefore, as a result of this, chances for prospective growth in the market for minimally invasive gastrointestinal surgical systems are becoming available. Additionally, there is a significant increase in the number of new manufacturers entering the market that are creating MIS surgical systems. A large increase in the number of sales of minimally invasive gastrointestinal surgical systems has been brought about all over the world as a direct result of these primary causes.
In the developing and emerging countries of Asia Pacific, Africa, and the Middle East, there is a shortage of skilled professionals, which is constraining the expansion of the market.
However, the government has recently undertaken a number of measures and made investments in academic institutions and research facilities, both of which should contribute to an improvement in the situation in the future.
The global market for minimally invasive gastrointestinal surgical systems is comprised of a big number of small-scale manufacturers and vendors in addition to a significant number of large-scale manufacturers. Presently, as a result of the expanding use of technologies in healthcare, the manufacturers already active in the market have access to a large number of chances to broaden the scope of their products and services and to consolidate their position as industry leaders.
The market is split by region into North America, Europe, Asia-Pacific, and LAMEA.
The report on the market for minimally invasive gastrointestinal surgical systems includes the following countries: the United States, Canada, and Mexico in the North American region; Germany, France, the United Kingdom, the Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey; the rest of Europe in the European region; China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, and the Philippines in the Asia-Pacific region; Saudi Arabia, the United Arab Emirates, South Africa, Egypt, and Israel in the Middle Eastern
As a result of an increase in the geriatric population, an increase in the growth of minimally invasive surgery devices, an increase in the amount spent on healthcare, and an increase in the quality of healthcare provided in this region, North America has established itself as the dominant player in the market for minimally invasive gastrointestinal surgical systems. During the period being forecasted, it is also anticipated that this region will experience a high growth share.
Report Metric | Details |
---|---|
Segmentations | |
By Product Type |
|
By Surgery |
|
By End-User |
|
Company Profiles | Medtronic Medical Devices Business Services Inc. Stryker Smith & Nephew Abbott Applied Biomedical LLC California Resources Corporation Microline Surgical Zimmer Biomet B. Braun Melsungen AG CONMED Corporation HOYA Corporation Applied Medical Resources Corporation Aesculap Inc. Johnson & Johnson Services Inc., Karl Storz Gmbh & Co. Kg Novatract Surgical Inc. REMA Medizintechnik GmbH Teleflex Incorporated Boston Scientific Corporation Given Imagin Ltd |
Geographies Covered | |
North America | U.S. Canada |
Europe | U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe |
APAC | China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific |
Middle East and Africa | UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA |
LATAM | Brazil Mexico Argentina Chile Colombia Rest of LATAM |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The market for minimally invasive gastrointestinal surgical systems can be broken down into distinct submarkets based on the product type, surgical procedure, and end-user. The growth among these categories will assist you in analysing the industries' minuscule growth segments, and it will give consumers a beneficial market overview as well as industry insights that will assist them in making strategic decisions about the identification of core market applications.
Traditional minimally invasive gastrointestinal surgical systems (miss), surgical robotics, and other types of minimally invasive gastrointestinal surgical systems make up the conventional segments of the market for minimally invasive gastrointestinal surgical systems.
In terms of surgery, the market for minimally invasive gastrointestinal surgical systems can be broken down into the following categories: adrenalectomy, appendectomy, bariatric surgery, cholecystectomy, colon and rectal surgery, foregut surgery, and hernia repair. Moreover, the market is broken down into these categories.
On the basis of the end-user, the market for minimally invasive gastrointestinal surgical systems can be further divided into two categories: conventional technologies and surgical robots.
Many market participants have turned to a range of strategies, such as the development of new products and the expansion of their respective businesses, in order to maintain their footing in the face of the intense rivalry that exists in the market.